Dimensional Fund Advisors’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-38,158
Closed -$707K – 3234
2026
Q2
$707K Sell
38,158
-2,663
-7% -$42.1K ﹤0.01% 2918
2026
Q1
$607K Buy
+40,821
New +$638K ﹤0.01% 2922
2025
Q4
– Sell
-11,215
Closed -$143K – 3253
2025
Q3
$143K Buy
+11,215
New +$96.5K ﹤0.01% 3158

Other funds holding AVTX

Dimensional Fund Advisors's AVTX Position: Q3 2026 in Review

Dimensional Fund Advisors sold out of Avalo Therapeutics (AVTX) in Q3 2026, closing a stake of 38,158 shares — an estimated $707K sold.

Dimensional Fund Advisors first reported a position in AVTX in Q3 2025 and held it in 3 quarters. The position peaked at $707K in Q2 2026. 148 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.

  • Dimensional Fund Advisors reported no remaining Avalo Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 38,158 Avalo Therapeutics shares in Q3 2026, an estimated $707K.
  • Dimensional Fund Advisors first reported a position in Avalo Therapeutics in Q3 2025 and held it in 3 quarters.
  • Dimensional Fund Advisors's Avalo Therapeutics position peaked at $707K in Q2 2026.
  • 148 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.